Drugs tested to stop COVID-19 pneumonia from getting worse
NCT ID NCT04581954
Summary
This study tested whether two existing anti-inflammatory drugs, ruxolitinib and fostamatinib, could help prevent hospitalized COVID-19 pneumonia patients from getting sicker. The goal was to see if these drugs could stop mild or moderate cases from progressing to severe pneumonia requiring breathing support. The trial involved 185 hospitalized adults and compared the drugs against standard hospital care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imperial College Healthcare NHS Trust
London, W12 0HS, United Kingdom
-
London North West University Healthcare
London, HA1 3UJ, United Kingdom
-
Royal Berkshire NHS Foundation Trust
Reading, RG1 5AN, United Kingdom
-
Sheffield Teaching Hospitals NHS Foundation Trust - Royal Hallamshire Hospital
Sheffield, S10 2JF, United Kingdom
-
The Leeds Teaching Hospital - St James University Hospitals NHS Trust
Leeds, LS9 7TF, United Kingdom
Conditions
Explore the condition pages connected to this study.